Work

Safety, Tolerability, Pharmacokinetics, and Brain Target Occupancy of the OGA Inhibitor ASN90 in Healthy Participants

Year: 2025

Type: article

Study design: Clinical Trial

Source: Movement Disorders

DOI: 10.1002/mds.70104

Authors: Rolf Pokorny, J. Michael Ryan, Khalid Abd‐Elaziz, Frans van den Berg, Eugenii Rabiner, Graham E. Searle, Manfred Schneider, Christoph Wiessner, Jean‐François Stallaert, Bruno Permanne, Anna Quattropani, Dirk Beher

Institutions: Asceneuron (Switzerland), École Polytechnique Fédérale de Lausanne, QPS (Netherlands), Hammersmith Medicines Research, King's College London, Hammersmith Hospital, Imperial College London

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416248164

FWCI: 2.184

Cites: 19

Cited by: 4

Related to: